A significant gathering of researchers, industry experts, and rising stars in glycomics recently took place in Edmonton, Alberta with the Honourable Randy Boissonnault, focusing on advancements and current trends in the field.
Category: Network News
Finding that the skin of people with scleroderma makes a unique sugar, GlycoNet researcher Lisa Willis is developing a way to better identify those at high risk of disease progression.
PlantForm Corporation has teamed up with a University of British Columbia research group led by Dr. Joerg Bohlmann to develop a novel plant-based treatment option for Type-2 diabetes and obesity, with support from GlycoNet.
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Applying a glycomics lens to the problem of organ donor-recipient compatibility, GlycoNet researcher Dr. Lori West is advancing the field of organ transplantation.
It’s all about monitoring sugar – but not in the way you may think
A spotlight on some of the most exciting glycomics innovations from the past year.
GlycoNet scientists at UBC have found a plant compound that helps control blood sugar levels in people with Type 2 diabetes.
GlycoNet scientist Mariela Segura is developing glycomics-based solutions to improve livestock health.
This partnership will launch the clinical trial of a new blood test to perfect early detection and diagnosis of clinically significant prostate cancer.